KRAS mutant protein inhibitor 1
KRAS mutant protein inhibitor 1 is a KRAS mutant protein inhibitor for potential research in cancer.
Product Specifications
CAS Number
2642630-16-6
UNSPSC
12352005
Target
Ras
Type
Reference compound
Related Pathways
GPCR/G Protein; MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/kras-mutant-protein-inhibitor-1.html
Solubility
10 mM in DMSO
Smiles
C=CC(N1CCN(CC1)C2=C(C(N(C3=NC(C4=C(C(Cl)=CC(Cl)=C4F)N)=C(C=C32)Cl)C5=C(C=CN=C5C(C)C)C)=O)C#N)=O
Molecular Formula
C31H27Cl3FN7O2
Molecular Weight
654.95
References & Citations
[1]Kargbo RB. Targeting KRAS Mutant Protein Inhibitor for Potential Treatment in Cancer. ACS Med Chem Lett. 2021 Oct 7;12 (11) :1633-1634.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC740965-100 1x 100 µL
MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (VU-11D1), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740253-500 1x 500 µL
Cytokeratin, LMW (AE-1), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC681003-100 1x 100 µL
Mucin 5AC (MUC5AC) (58M1), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC041073-500 1x 500 µL
HLA-Aw32 & HLA-A25 (MHC I) (CATA-1), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 